Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)

CNY 31.9

(0.73%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 10.23 Billion 10.15 Billion 9.06 Billion 8.28 Billion 7.84 Billion 7.1 Billion
Total Current Assets 6.55 Billion 7.24 Billion 6.42 Billion 5.6 Billion 5.13 Billion 4.78 Billion
Cash And Short Term Investments 2.14 Billion 2.88 Billion 2.28 Billion 1.98 Billion 1.52 Billion 1.52 Billion
Cash and Cash Equivalents 2.12 Billion 2.88 Billion 2.28 Billion 1.98 Billion 1.47 Billion 1.46 Billion
Short Term Investments 20.3 Million 40.61 Million -22.76 Million -28.81 Million 43.52 Million 53.3 Million
Net Receivables 2.72 Billion 2.85 Billion 2.05 Billion 2.05 Billion 1.92 Billion 1.86 Billion
Inventory 1.56 Billion 1.42 Billion 1.52 Billion 1.48 Billion 1.59 Billion 1.32 Billion
Other Current Assets 117.11 Million 76.82 Million 556.86 Million 71.72 Million 88.63 Million 63.46 Million
Total Non-Current Assets 3.67 Billion 2.91 Billion 2.64 Billion 2.67 Billion 2.7 Billion 2.32 Billion
Net PPE 1.44 Billion 1.46 Billion 1.48 Billion 1.45 Billion 1.36 Billion 1.19 Billion
Good Will And Intangible Assets 396.73 Million 376.82 Million 202.9 Million 204.02 Million 175.57 Million 174.85 Million
Good Will 65.91 Million 84.69 Million - - - -
Intangible Assets 330.82 Million 292.13 Million 202.9 Million 204.02 Million 175.57 Million 174.85 Million
Long-Term Investments 895.7 Million 815.56 Million 763.5 Million 832.66 Million 863.38 Million 719.7 Million
Tax Assets 265.99 Million 208.35 Million 154.6 Million 165.48 Million 183.8 Million 133.28 Million
Other Non Current Assets 678.48 Million 46.21 Million 34.74 Million 17.95 Million 118.26 Million 97.74 Million
Other Assets - - 1.00 - - -
Total Liabilities 3.49 Billion 3.6 Billion 2.55 Billion 2.33 Billion 2.31 Billion 2.05 Billion
Total Current Liabilities 3.23 Billion 3.33 Billion 2.43 Billion 2.16 Billion 2.15 Billion 1.91 Billion
Account Payables 615.38 Million 1.4 Billion 1.24 Billion 902.25 Million 666.65 Million 600.61 Million
Tax Payables 76.67 Million 196.85 Million 44.07 Million 42.68 Million 112.27 Million 97.14 Million
Short Term Debt 596.07 Million 105.73 Million 31.59 Million 1 Million 962.03 Thousand 252 Million
Deferred Revenue 145.65 Million 219.07 Million 215.6 Million 246.66 Million 1.48 Billion 97.14 Million
Other Current Liabilities 1.87 Billion 1.6 Billion 944.19 Million 1.01 Billion 962.03 Thousand 964.3 Million
Total Non Current Liabilities 259.26 Million 271.59 Million 119.35 Million 169.64 Million 162.76 Million 136.84 Million
Long-Term Debt 241.03 Million 152.17 Million 1.57 Million 31.7 Million 32.71 Million 38.78 Million
Deferred Revenue Non Current 57.14 Million 59.87 Million 59.14 Million 63.34 Million 44.94 Million 50.7 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -46.25 Million 50.72 Million 54.42 Million 70.78 Million 76.17 Million 41.44 Million
Other Liabilities 1.00 1.00 - - 1.00 -
Total Equity 6.64 Billion 6.55 Billion 6.51 Billion 5.94 Billion 5.52 Billion 5.05 Billion
Stock Holders Equity 6.6 Billion 6.52 Billion 6.36 Billion 5.8 Billion 5.38 Billion 4.92 Billion
Common Stock 770.15 Million 773.44 Million 773.44 Million 773.64 Million 772.8 Million 768.87 Million
Retained Earnings 4.39 Billion 4.26 Billion 3.78 Billion 3.24 Billion 2.77 Billion 2.31 Billion
Accumulated other comprehensive income 587.71 Million 601.88 Million 605.22 Million 587.63 Million 640.45 Million 633.72 Million
Common Stock Equity 6.6 Billion 6.52 Billion 6.36 Billion 5.8 Billion 5.38 Billion 4.92 Billion
Capital Lease Obligation 2.74 Million 871.42 Thousand 1.57 Million 1.7 Million 2.71 Million 3.68 Million
Total Investments 916 Million 801.46 Million 740.74 Million 803.84 Million 906.9 Million 773.01 Million
Total Debt 839.84 Million 257.9 Million 33.16 Million 32.71 Million 33.67 Million 252 Million
Net Debt -1.28 Billion -2.62 Billion -2.25 Billion -1.95 Billion -1.44 Billion -1.21 Billion

Balance Sheet Charts